Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses
Roshell Muir, Talibah Metcalf, Slim Fourati, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 7, pp. e0011089-e0011089
Open Access | Times Cited: 17

Showing 17 citing articles:

Beyond schistosomiasis: unraveling co-infections and altered immunity
Dilhan J. Perera, Cal Koger-Pease, Kayla Paulini, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 1
Closed Access | Times Cited: 5
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
Gyaviira Nkurunungi, Jacent Nassuuna, Agnes Natukunda, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 11, pp. e1826-e1837
Open Access | Times Cited: 4
Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
Brice Armel Nembot Fogang, Linda Batsa Debrah, Michael Owusu, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 436-436
Open Access
Impact of Schistosoma mansoni Infection on the Gut Microbiome and Hepatitis B Vaccine Immune Response in Fishing Communities of Lake Victoria, Uganda
Yan Wang, A. Waters, Geofrey Basalirwa, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 375-375
Open Access
Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies
Violet Ankunda, Joseph Ssebwana Katende, Gerald Kevin Oluka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
A systematic review reveals that African children of 15–17 years demonstrate low hepatitis B vaccine seroprotection rates
Fahad Muwanda, Hakim Sendagire, Gerald Mboowa, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort
Jennifer Serwanga, Laban Kato, Violet Ankunda, et al.
(2024)
Open Access | Times Cited: 1
Schistosome Transgenesis: The Long Road to Success
Bernd H. Kalinna, Allen G. Ross, Anna K. Walduck
Biology (2024) Vol. 13, Iss. 1, pp. 48-48
Open Access | Times Cited: 1
IL‐21‐IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection
Suresh Pallikkuth, Daniel Kvistad, Tirupataiah Sirupangi, et al.
Aging Cell (2023) Vol. 22, Iss. 11
Open Access | Times Cited: 2
The Effect of Intensive Praziquantel Treatment on Vaccine-Specific Responses Among Schoolchildren in Ugandan Schistosomiasis-Endemic Islands: Results of the Popvac a Randomised, Controlled Trial
Gyaviira Nkurunungi, Jacent Nassuuna, Agnes Natukunda, et al.
(2023)
Closed Access | Times Cited: 2
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles
Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0303113-e0303113
Open Access
COVID-19 vaccination survey and anti-SARS-CoV-2 S1 IgG responses in a human cohort from Schistosoma mansoni-endemic villages in Mayuge, Uganda: A cross-sectional study
Mimi Niu, Yi Mu, Moses Adriko, et al.
Research Square (Research Square) (2024)
Open Access
COVID-19 vaccination survey and anti-SARS-CoV-2 IgG responses in a human cohort from Schistosoma mansoni-endemic villages in Mayuge District, Uganda: a cross-sectional study
Mimi Niu, Yi Mu, Moses Adriko, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies
Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, et al.
(2023)
Open Access | Times Cited: 1
The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort
Jennifer Serwanga, Laban Kato, Gerald Kevin Oluka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Intensify praziquantel administration to reverse vaccine hyporesponsiveness in LMICs?
Justin Komguep Nono
The Lancet Global Health (2024) Vol. 12, Iss. 11, pp. e1746-e1747
Open Access
Page 1

Scroll to top